Review and approval process:

Projects are reviewed in a two stage process;

  1. Firstly a scope assessment is conducted by the Programme Manager to identify projects that meet the scope criteria.
  2. A second review stage is then initiated in which the targets of interest are considered for their scientific, legal, intellectual property, and commercial aspects.

Projects which successfully pass triage are presented to the Consortium Members for their consideration. Applications which receive two or more expressions of interest from the Consortium Members are progressed for project development in collaboration with one of our Partner Organisations. This is an iterative and fully collaborative process between the applicant(s), MDC and Consortium Members, capitalising on their drug discovery and development expertise to generate a robust and detailed experimental and project plan.

This process is outlined in further detail in our webinar